MARKET SURVEY OF ANTITUBERCULOSIS DRUGS IN INDIA

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 7

Abstract

Tuberculosis (TB) is a contagious disease. It is worldwide occurring disease affecting millions of people. A WHO report in 2011 show that almost 8.7 million people is in apprehension of Tuberculosis. Tuberculosis commonly affects to lungs but other body part is also susceptible to develop tuberculosis viz. brain, bone, spine, kidney, lymph node. Mycobacterium tuberculosis a gram positive bacteria is responsible for this contagious disease. Streptomycin is the first drug invented to treat tuberculosis. Some other also useful anti-tuberculosis drugs are invented like isoniazid, ethambutol, rifampin, pyrazinamide. Due to noncompliance and other reasons drug resistance should be developed in patients then other drugs come in addition like gatifloxacin, ethionamide, aminosalicylic acid, cycloserine, amikacin etc but these drugs have high toxic effects than first line drugs. WHO begun a programme to fight against tuberculosis named DOTS (Directly Observed Treated,Shortcourse). This study approved that the selling of first line drugs viz. ethambutol, isoniazid, rifampin, pyrazinamide and their combination is more than the second line drugs in India.

Authors and Affiliations

Ashish Pandey*| Sunder Deep Pharmacy College, Ghaziabad, UP, India, Satish Kumar Sharma| Sunder Deep Pharmacy College, Ghaziabad, UP, India, Lalit Singh| Sunder Deep Pharmacy College, Ghaziabad, UP, India, Tanuja Singh| Sunder Deep Pharmacy College, Ghaziabad, UP, India

Keywords

Related Articles

TREATMENT AND MANAGEMENT OF DIABETES WITH STEM CELL THERAPY: A NEWER SCIENTIFIC APPRAOCH

Diabetes is usually a lifelong (chronic) disease in which there are high levels of sugar in the blood. Diabetes, often referred to by doctors as diabetes mellitus, describes a group of metabolic diseases in which the per...

An overview of Chrono-pharmaceuticals drug delivery systems: Recent advances

Chrono-pharmaceutics includes pharmaceutical application of “Chronobiology” in drug delivery. Chronobiology is the study of biological rhythms and their responses to other metabolic functions of body. Diseases such as br...

Antibacterial activity of Citrus aurantium leaf essential oil against S.aureus and MRSA

Plants based antimicrobials effective in the treatment of infectious diseases and also devoid of side effects which associated with synthetic one. To evaluate antibacterial effect of Citrus aurantium leaf essential oil a...

PERSPECTIVES OF AMLA – A WONDER HERB

Emblica officinalis has been held in high esteem in indigenous medicine. Amla is a commonly used ingredient in the Ayurvedic preparation in the form of fresh fruits, dried fruits, fruit pulp or extract. Traditionally, am...

Emerging drug discovery paradigm in non small cell lung cancer: pharmacophore modeling, atom-based 3D- QSAR and virtual screening of novel EGFR inhibitors

EGFR is a significant drug target approached in the domain of the wide prevailing cancer type, non- small cell lung cancer and search for its potent inhibitor is an emerging opportunity in cancer drug discovery. Computat...

Download PDF file
  • EP ID EP1422
  • DOI -
  • Views 429
  • Downloads 29

How To Cite

Ashish Pandey*, Satish Kumar Sharma, Lalit Singh, Tanuja Singh (2013). MARKET SURVEY OF ANTITUBERCULOSIS DRUGS IN INDIA. Journal of Drug Discovery and Therapeutics, 1(7), 63-66. https://europub.co.uk/articles/-A-1422